BiotechTube

DRM02

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Oct 1, 2013 → Mar 1, 2014

NCT ID
NCT01993446

About DRM02

DRM02 is a phase 2 stage product being developed by Eli Lilly for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01993446. Target conditions include Rosacea.

What happened to similar drugs?

5 of 15 similar drugs in Rosacea were approved

Approved (5) Terminated (2) Active (8)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic acid 15% + Brimonidine 0.33%BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT01993446Phase 2Completed
NCT01993433Phase 2Completed
NCT01993420Phase 2Completed

Competing Products

20 competing products in Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-04 OintmentDr. Reddy's LaboratoriesPhase 2
32
Minocycline hydrochloride capsulesDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 Extended Release Capsules (40 mg) + DFD-29 Extended Release Capsules (20 mg) + Oraycea® (doxycycline) Capsules + Placebo CapsulesDr. Reddy's LaboratoriesPhase 2
32
DoxycyclineDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
36
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
42
Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + PlaceboSun PharmaceuticalPhase 1
29
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
29
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
29
Laropiprant + Placebo for LaropiprantMerckPhase 1
29
AMG 334NovartisPhase 2
31
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
35
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Coppertone, BAY1183345BayerPre-clinical
23
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40